Correlation Between Merck and Nuvectis Pharma

Can any of the company-specific risk be diversified away by investing in both Merck and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Merck Company and Nuvectis Pharma, you can compare the effects of market volatilities on Merck and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Nuvectis Pharma.

Diversification Opportunities for Merck and Nuvectis Pharma

0.29

Correlation Coefficient

Merck  Nuvectis Pharma

Modest diversification

The 3 months correlation between Merck and Nuvectis is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Merck i.e., Merck and Nuvectis Pharma go up and down completely randomly.

Pair Corralation between Merck and Nuvectis Pharma

Considering the 90-day investment horizon Merck Company is expected to under-perform the Nuvectis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 4.74 times less risky than Nuvectis Pharma. The stock trades about -0.12 of its potential returns per unit of risk. The Nuvectis Pharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  674.00  in Nuvectis Pharma on October 20, 2024 and sell it today you would lose (125.00) from holding Nuvectis Pharma or give up 18.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Merck Company  vs.  Nuvectis Pharma

Merck Company

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Nuvectis Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Merck and Nuvectis Pharma

The main advantage of trading using opposite Merck and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.

The idea behind Merck Company and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.